Serum sickness is a classic type III hypersensitivity reaction. It happens when foreign proteins, typically from animal-source antisera, enter the human body. The immune system flags these foreign proteins as dangerous invaders and launches an antibody response. Unlike immediate allergic reactions that happen in minutes, serum sickness takes between one to three weeks to develop. This delay occurs because the body needs time to manufacture specific antibodies against the foreign proteins. Once enough antibodies circulate, they bind to the foreign antigens and create immune complexes.
The underlying mechanism of serum sickness revolves around circulating immune complexes. When antibodies meet foreign antigens in the bloodstream, they form antigen-antibody complexes. Normally, the reticuloendothelial system clears these complexes easily. However, when antigens are present in excess, medium-to-large immune complexes form and linger in the circulation. These circulating complexes drift into small blood vessels, joints, and renal glomeruli. Once trapped in these tissues, they trigger the complement cascade, attracting neutrophils and releasing inflammatory mediators that damage local tissue.
Patients with serum sickness present with a recognizable triad of signs. Fever and malaise usually appear first, signaling systemic inflammation. Skin eruptions follow closely, most notably an itchy, urticarial, or maculopapular rash that often starts at the site of injection. Polyarthralgia affecting large joints like the knees, wrists, and ankles is nearly universal. Lymphadenopathy, particularly in areas near the exposure site, is also common. Symptoms are generally self-limiting and resolve once the offending antigen clears from the body.
A thorough nursing assessment focuses on tracking the timeline of symptom onset relative to recent drug or antivenom administration. Nurses must inspect the skin for rash distribution, palpate lymph nodes, and assess joint mobility and tenderness. Laboratory evaluations typically show elevated inflammatory markers like Erythrocyte Sedimentation Rate and C-reactive protein. Urinalysis is crucial to screen for proteinuria and microscopic hematuria, which indicate early immune complex deposition in the renal glomeruli. A complete blood count may reveal transient leukopenia or leukocytosis.
Medical management aims to relieve symptoms and suppress the hyperactive immune response. The primary intervention is immediate discontinuation of the offending drug or antiserum. Antihistamines are prescribed to manage pruritus and the urticarial rash. Non-steroidal anti-inflammatory drugs help control fever and joint pain. For severe cases involving major organ systems, systemic corticosteroids are initiated to rapidly suppress inflammation and clear the immune complexes.
Nursing care prioritizes comfort, symptom relief, and patient education. Nurses administer prescribed analgesics, antihistamines, and anti-inflammatory drugs on schedule. Warm or cool compresses can soothe aching joints, while soothing lotions help manage pruritus and prevent skin breakdown from scratching. Patient education focuses on identifying the causative agent so the individual can avoid future exposures. Nurses must clearly explain the importance of checking medication labels and informing all healthcare providers about past allergic reactions.
The overall prognosis for serum sickness is excellent, as the condition is typically self-limiting once the antigen is eliminated. Most patients recover fully within one to two weeks with minimal intervention. However, rare complications can occur if immune complexes deposit heavily in critical organs. Glomerulonephritis, peripheral neuritis, and vasculitis represent more severe sequelae requiring aggressive medical therapy. Long-term organ damage is rare if the condition is recognized and treated promptly.